| Product Code: ETC6208000 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Non-alcoholic Steatohepatitis Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Non-alcoholic Steatohepatitis Market - Industry Life Cycle |
3.4 Austria Non-alcoholic Steatohepatitis Market - Porter's Five Forces |
3.5 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.7 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Disease Cause, 2021 & 2031F |
3.8 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Austria Non-alcoholic Steatohepatitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity and diabetes in Austria, which are major risk factors for non-alcoholic steatohepatitis (NASH) |
4.2.2 Growing awareness about NASH among healthcare professionals and patients leading to early diagnosis and treatment |
4.2.3 Rising investments in research and development for NASH therapies by pharmaceutical companies |
4.3 Market Restraints |
4.3.1 Limited availability of approved treatment options for NASH in Austria |
4.3.2 High cost associated with NASH treatment and management leading to affordability issues for patients |
4.3.3 Lack of standard guidelines for diagnosis and management of NASH in Austria |
5 Austria Non-alcoholic Steatohepatitis Market Trends |
6 Austria Non-alcoholic Steatohepatitis Market, By Types |
6.1 Austria Non-alcoholic Steatohepatitis Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F |
6.1.4 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Ocaliva, 2021- 2031F |
6.1.5 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Elafibranor, 2021- 2031F |
6.1.6 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Selonsertib and Cenicriviroc, 2021- 2031F |
6.1.7 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obeticholic Acid, 2021- 2031F |
6.1.8 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Austria Non-alcoholic Steatohepatitis Market, By Sales Channel |
6.2.1 Overview and Analysis |
6.2.2 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Online Providers, 2021- 2031F |
6.2.4 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3 Austria Non-alcoholic Steatohepatitis Market, By Disease Cause |
6.3.1 Overview and Analysis |
6.3.2 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hypertension, 2021- 2031F |
6.3.3 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Heart Disease, 2021- 2031F |
6.3.4 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By High Blood Lipid, 2021- 2031F |
6.3.5 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F |
6.3.6 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obesity, 2021- 2031F |
6.4 Austria Non-alcoholic Steatohepatitis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Austria Non-alcoholic Steatohepatitis Market Revenues & Volume, By Homecare settings, 2021- 2031F |
7 Austria Non-alcoholic Steatohepatitis Market Import-Export Trade Statistics |
7.1 Austria Non-alcoholic Steatohepatitis Market Export to Major Countries |
7.2 Austria Non-alcoholic Steatohepatitis Market Imports from Major Countries |
8 Austria Non-alcoholic Steatohepatitis Market Key Performance Indicators |
8.1 Percentage increase in the number of NASH diagnoses in Austria |
8.2 Adoption rate of new NASH treatment options in the market |
8.3 Patient adherence to NASH treatment regimens |
8.4 Average time taken for NASH diagnosis and treatment initiation |
8.5 Number of clinical trials conducted for NASH therapies in Austria |
9 Austria Non-alcoholic Steatohepatitis Market - Opportunity Assessment |
9.1 Austria Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Austria Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.3 Austria Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Disease Cause, 2021 & 2031F |
9.4 Austria Non-alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Austria Non-alcoholic Steatohepatitis Market - Competitive Landscape |
10.1 Austria Non-alcoholic Steatohepatitis Market Revenue Share, By Companies, 2024 |
10.2 Austria Non-alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here